�����г���Ƶ

Patient testing is underway for a new therapy for age-related macular degeneration (AMD) developed by the John A. Moran Eye Center’s Sharon Eccles Steele Center for Translational Medicine (SCTM).

The Ophthalmologist magazine has named four John A. Moran Eye Center leaders in care and research to its 2023 Power List of the 100 most influential people in ophthalmology worldwide.

In appreciation of decades of ongoing care, the Cumming Foundation has created an endowed chair for Moran CEO Randall J Olson, MD.

John A. Moran Eye Center volunteers provided 110 eye exams and 110 pairs of eyeglasses at Salt Lake City's 2023 Project Homeless Connect.

The FDA is warning consumers not to purchase and immediately stop using EzriCare Artificial Tears, Delsam Pharma’s Artificial Tears, and Delsam Pharma’s Artificial Eye Ointment due to potential bacterial contamination.

John A. Moran Eye Center surgeon-scientist Eileen Hwang, MD, PhD, is working to advance our understanding of the vitreous to develop new treatments for patients.

Beyond a range of everyday vision-correcting options in rigid and soft contact lenses, the John A. Moran Eye Center provides patients with access to new generations of specialty contacts for...

As the John A. Moran Eye Center’s first ophthalmic hospitalist, Theresa Long, MD, is breaking new ground in resident education and patient care.

Conducting the first large-scale eye study of its kind on the Navajo Nation, John A. Moran Eye Center researchers determined cataracts and the unmet need for eyeglasses are the top...

Daisy Callister's experience with retinoblastoma inspired “Mina and Her New Eye,” a new �����г���Ƶren's book created by the Patient Support Program at the John A. Moran Eye Center.

The John A. Moran Eye Center’s nonprofit Utah Lions Eye Bank (ULEB) recently celebrated 50 years of working with eye tissue donors and their families to provide corneal tissue for...

Some of the biggest leaps researchers at the Alan S. Crandall Center for Glaucoma Innovation at the John A. Moran Eye Center are taking come in small packages.

The John A. Moran Eye Center and its Patient Support Program is partnering with the Utah Opera to help the blind and visually impaired experience the visual storyline of opera...

The Moran Eye Center's monthly donor-funded clinic through Moran’s Global Outreach Division is entering its second year of serving uninsured and under-insured Utahns with diabetes and other sight-threatening retinal conditions.

The John A. Moran Eye Center’s new Alan S. Crandall Center for Glaucoma Innovation is poised to contribute to a quantum leap forward in glaucoma treatment and care.

Eye care leaders around the country have voted the John A. Moran Eye Center at the �����г���Ƶ of Utah among the nation’s Top 10 programs when it comes to patient...

The John A. Moran Eye Center recently welcomed Deepika Bagga, OD, to its �����г���Ƶ of Utah and Midvalley clinics.

Research to Prevent Blindness (RPB) has selected the John A. Moran Eye Center at the �����г���Ƶ of Utah to receive an unrestricted annual grant of $115,000 to support eye research.

Building on her academic and clinical relationship with the John A. Moran Eye Center, Theresa Long, MD, will serve as the institution’s first ophthalmic hospitalist.

The Achievement Rewards for College Scientists (ARCS) Foundation of Utah has selected two incoming John A. Moran Eye Center residents to receive its 2023-2024 research scholarships.

Moran Eye Center clinician-scientist Ike Ahmed, MD, FRCSC, outlines new approaches in supraciliary micro-invasive glaucoma surgery (MIGS).

John A. Moran Eye Center scientist Mary Elizabeth Hartnett, MD, is one of four vision scientists nationwide selected to receive the American Academy of Ophthalmology (AAO) and Research to Prevent...

Mark Mifflin, MD, of the John A. Moran Eye Center at the �����г���Ƶ of Utah has been named Top Doc 2022 by the National Keratoconus Foundation.

A new, $1.9 million National Eye Institute (NEI) grant will allow John A. Moran Eye Center scientists to answer a fundamental question about the eye’s response to age-related macular degeneration...